Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer

Table 2 Results of survey for chemotherapy toxicity

No	No chemotherapy	First-line chemotherapy		Second-line chemotherapy
No	No chemotherapy		Relative value		Relative value
1	95	85	0.895	75	0.789
2	95	75	0.789	50	0.526
3	80	70	0.875	65	0.813
4	95	70	0.737	50	0.526
5	95	70	0.737	50	0.526
6	90	70	0.778	50	0.556
7	95	80	0.842	50	0.526
8	100	80	0.8	60	0.6
9	90	85	0.944	60	0.667
10	95	80	0.842	65	0.684
11	90	80	0.889	60	0.667
12	90	70	0.778	50	0.556
13	90	80	0.889	70	0.778
14	85	58	0.682	37	0.435
15	100	90	0.9	87	0.87
16	100	100	1	96	0.96
17	100	99	0.99	93	0.93
18	95	70	0.737	45	0.474
19	100	80	0.8	50	0.5
20	85	70	0.824	50	0.588
21	95	75	0.789	50	0.526
22	90	80	0.889	40	0.444
23	95	85	0.895	60	0.632
24	90	80	0.889	60	0.667
Average			0.841		0.635
SD			0.081		0.151

ISSN: 1472-6947